You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國務院:擴大醫用耗材集中帶量採購範圍 將醫療新藥器械應用等納入保險保障範圍
國務院辦公廳印發「十四五」全民醫療保障規劃提出,到2025年,醫療保障制度更加成熟定型,基本完成待遇保障、籌資運行、醫保支付、基金監管等重要機制和醫藥服務供給、醫保管理服務等關鍵領域的改革任務,醫療保障政策規範化、管理精細化、服務便捷化、改革協同化程度明顯提升。醫療保障信息化水平顯着提升,全國統一的醫療保障信息平臺全面建成,「互聯網+醫療健康」醫保服務不斷完善,醫保大數據和智能監控全面應用,醫保電子憑證普遍推廣,就醫結算更加便捷,以市場爲主導的醫藥價格和採購機制更加完善,醫療服務價格調整更加靈敏有度。 意見並提出,將持續擴大國家組織高值醫用耗材集中帶量採購範圍。完善與集中帶量採購相配套的激勵約束機制,落實醫保資金結餘留用政策,推動集中帶量採購成爲公立醫療機構醫藥採購的主導模式,鼓勵社會辦醫療機構、定點零售藥店參與集中帶量採購。強化藥品和醫用耗材價格常態化監管,實施全國醫藥價格監測工程,全面落實醫藥價格和招採信用評價制度,遏制藥品和醫用耗材價格虛高,兼顧企業合理利潤,促進醫藥行業高質量發展。 此外,將鼓勵商業保險機構提供醫療、疾病、康復、照護、生育等多領域的綜合性健康保險產品和服務,逐步將醫療新技術、新藥品、新器械應用納入商業健康保險保障範圍。支持商業保險機構與中醫藥機構合作開展健康管理服務,開發中醫治未病等保險產品等。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account